World

Insufficient evidence to link bomb threats across Europe to foreign powers: Macron

Nov 13, 2026

Istanbul [Turkey], November 13: French President Emmanuel Macron said on Thursday there was insufficient evidence to determine whether foreign powers were behind a wave of bomb threats across Europe.
"At this point, we do not have sufficiently established evidence to make an attribution. At this stage, we cannot say that foreign powers are behind these calls," Macron told reporters on the sidelines of a European leaders' summit in Dublin.
He said he would convene a meeting of the Defense and Security Council in the coming days to discuss the threats.
"We are obviously very vigilant in the face of this epidemic of bomb alerts and threats," Macron said.
Several incidents were reported in France on Thursday, including a bomb alert at Calais railway station that disrupted rail services and another at a high school in Marseille that prompted an evacuation.
Classes at the school resumed after security checks found no threat.
Italy also faced a wave of bomb threats targeting schools Wednesday, prompting evacuations and security checks. Italian Prime Minister Giorgia Meloni said authorities had found no evidence of a concrete danger.
Hundreds of schools across the UK and Ireland have also received bomb threats, raising concerns about a possible broader campaign of hybrid threats across Europe.
Source: Qatar Tribune

More news

Indian Research on Young-Onset Parkinson's Disease Receives Recognition at Global GP2 Conference

Bengaluru (Karnataka) [India], November 13: A study conducted by the Parkinson’s Research Alliance of India (PRAI) on the genetic basis of early-onset Parkinson’s disease (PD) in Indian patients has received international recognition as it won the “Best Poster” award at the Global Parkinson’s Genetics Program (GP2) Annual Conference held in Seoul, South Korea, in October 2026. The Global Parkinson’s Genetics Program (GP2), an initiative under Aligning Science Across Parkinson’s (ASAP), brings together researchers worldwide to advance the understanding of Parkinson’s disease genetics with a focus on populations historically underrepresented in research, and support globally relevant discoveries that can inform future therapeutic strategies.

Nov 13, 2026